demonstrated that CTLA-4 expression > 25% on CD4+ T cells was associated with a 3.2-fold increased risk of 28-day mortality, supporting its role in patient stratification for anti-CTLA-4 therapies for sepsis related immunosuppression (126). Here, CTLA4 is linked to Sepsis.